Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Autologous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke
NCT02178657Phase 2Completed
- Sponsor
- Red Andaluza de Terapias Avanzadas
- Start
- Apr 2015
- Primary completion
- Oct 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in ischemic stroke, sponsored by Red Andaluza de Terapias Avanzadas. Started Apr 2015; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02178657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178657.